Long-term exposure of RN46A cells expressing serotonin transporter (SERT) to a cAMP analog up-regulates SERT activity and is accompanied by neural differentiation of the cells

Journal of Pharmacological Sciences

Volumn 121, Issue 1, 2013, Pages 25-38

  Yammamoto, Hikaru ^a   Tanaka, Shigeru ^a   Tanaka, Anna ^a   Hide, Izumi ^a   Seki, Takahiro ^a   Sakai, Norio ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Membrane trafficking; Neural differentiation; Serotonin transporter

Indexed keywords

CYCLIC AMP DERIVATIVE; MESSENGER RNA; SEROTONIN TRANSPORTER;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; METABOLIC INHIBITION; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAPHE NUCLEUS; RAT; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84873844845     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12229FP     Document Type: Article

References (47)

1. Stahl SM. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 2nd ed. Cambridge: Cambridge University Press; 2000.
2. Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 1991;354:66-70.
3. Kuhar MJ, Roth RH, Aghajanian GK. Synaptosomes from fore-brains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther. 1972;181:36-45.
4. Han DD, Gu HH. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol. 2006;6:6.
5. Olivier B, Soudijn W, van Wijngaarden I. Serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors. Prog Drug Res. 2000;54:59-119.
6. Rudnick G, Wall SC. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter. Mol Pharmacol. 1991;40:421-426.
7. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
8. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
9. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry. 2003;8:933-936.
10. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD. Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci. 2009;364: 163-173.
11. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet. 2005;77:265-279.
12. Vaughan RA. Phosphorylation and regulation of psychostimulant-sensitive neurotransmitter transporters. J Pharmacol Exp Ther. 2004;310:1-7.
13. Ramamoorthy S, Blakely RD. Phosphorylation and sequestration of serotonin transporters differentially modulated by psycho-stimulants. Science. 1999;285:763-766.
14. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem. 1998;273:2458-2466.
15. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci. 1997;17:45-57.
16. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci. 2005; 25:29-41.
17. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol. 2004;65:1462-1474.
18. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. 1998;44:169-178.
19. Morikawa O, Sakai N, Obara H, Saito N. Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol. 1998;349: 317-324.
20. Anderson GM, Horne WC, Chatterjee D, Cohen DJ. The hyper-serotonemia of autism. Ann N Y Acad Sci. 1990;600:331-340.
21. Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T, et al. Altered serotonin synthesis in the denta-tothalamocortical pathway in autistic boys. Ann Neurol. 1997; 42:666-669.
22. Miyazaki K, Narita N, Narita M. Maternal administration of thali-domide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism. Int J Dev Neurosci. 2005;23:287-297.
23. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K, et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell. 2009; 137:1235-1246.
24. Tamada K, Tomonaga S, Hatanaka F, Nakai N, Takao K, Miyakawa T, et al. Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling. PloS One. 2010;5:e15126.
25. Hendricks TJ, Fyodorov DV, Wegman LJ, Lelutiu NB, Pehek EA, Yamamoto B, et al. Pet-1 ETS gene plays a critical role in 5-HT neuron development and is required for normal anxietylike and aggressive behavior. Neuron. 2003;37:233-247.
26. Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT. Neu-ronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J Neurosci. 2001;21:4731-4739.
27. Eaton MJ, Staley JK, Globus MY, Whittemore SR. Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor and membrane depolarization. Dev Biol. 1995;170:169-182.
28. Tanaka S, Ishii K, Kasai K, Yoon SO, Saeki Y. Neural expression of G protein-coupled receptors GPR3, GPR6, and GPR12 up-regulates cyclic AMP levels and promotes neurite outgrowth. J Biol Chem. 2007;282:10506-10515.
29. White LA, Eaton MJ, Castro MC, Klose KJ, Globus MY, Shaw G, et al. Distinct regulatory pathways control neurofilament expression and neurotransmitter synthesis in immortalized serotonergic neurons. J Neurosci. 1994;14:6744-6753.
30. Seki T, Shimahara T, Yamamoto K, Abe N, Amano T, Adachi N, et al. Mutant gammaPKC found in spinocerebellar ataxia type 14 induces aggregate-independent maldevelopment of dendrites in primary cultured Purkinje cells. Neurobiol Dis. 2009;33: 260-273.
31. Yamamoto K, Seki T, Adachi N, Takahashi T, Tanaka S, Hide I, et al. Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy. Genes Cells. 2010;15:425-438.
32. Kajimoto T, Shirai Y, Sakai N, Yamamoto T, Matsuzaki H, Kikkawa U, et al. Ceramide-induced apoptosis by translocation, phosphorylation, and activation of protein kinase Cdelta in the Golgi complex. J Biol Chem. 2004;279:12668-12676.
33. Nobukuni M, Mochizuki H, Okada S, Kameyama N, Tanaka A, Yamamoto H, et al. The C-terminal region of serotonin transporter is important for its trafficking and glycosylation. J Pharmacol Sci. 2009;111:392-404.
34. Seki T, Adachi N, Ono Y, Mochizuki H, Hiramoto K, Amano T, et al. Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death. J Biol Chem. 2005;280:29096-29106.
35. Mochizuki H, Amano T, Seki T, Matsubayashi H, Mitsuhata C, Morita K, et al. Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT). Neurochem Int. 2005; 46:93-105.
36. Sakai N, Sasaki K, Nakashita M, Honda S, Ikegaki N, Saito N. Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/threonine phosphatases. J Neurochem. 1997;68:2618-2624.
37. Gloerich M, Bos JL. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol. 2010;50:355-375.
38. Peace AG, Shewan DA. New perspectives in cyclic AMP-mediated axon growth and guidance: The emerging epoch of Epac. Brain Res Bull. 2011;84:280-288.
39. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, et al. Epac is a Rap1 guanine-nucleotide-ex-change factor directly activated by cyclic AMP. Nature. 1998; 396:474-477.
40. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, et al. A family of cAMP-binding proteins that directly activate Rap1. Science. 1998;282:2275-2279.
41. Yamamoto H, Fujimiya M, Shirai Y, Nakashita M, Oyasu M, Saito N. Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain. Neurosci Res. 1998;32:305-312.
42. Uhlenbrock K, Gassenhuber H, Kostenis E. Sphingosine 1-phos-phate is a ligand of the human gpr3, gpr6 and gpr12 family of constitutively active G protein-coupled receptors. Cell Signal. 2002;14:941-953.
43. Mouri A, Sasaki A, Watanabe K, Sogawa C, Kitayama S, Mamiya T, et al. MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation. J Neurosci. 2012;32:4562-4580.
44. Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, et al. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell. 2003;115:851-862.
45. Walther DJ, Stahlberg S, Vowinckel J. Novel roles for biogenic monoamines: from monoamines in transglutaminase-mediated post-translational protein modification to monoaminylation deregulation diseases. FEBS J. 2011;278:4740-4755.
46. Dai Y, Dudek NL, Patel TB, Muma NA. Transglutaminase-cata-lyzed transamidation: a novel mechanism for Rac1 activation by 5-hydroxytryptamine2A receptor stimulation. J Pharmacol Exp Ther. 2008;326:153-162.
47. Watts SW, Priestley JR, Thompson JM. Serotonylation of vascular proteins important to contraction. PloS One. 2009;4:e5682.